(Total Views: 225)
Posted On: 05/22/2022 4:31:02 PM
Post# of 3588

$PBIO Pressure BioSciences, Inc to Access Early Revenue Generating Opportunities for UST Processing of High Quality Nanoemulsions of Oil-Based Active Ingredients for Multiple Markets Ahead of Q4 2022 Commercialization - Company Expects Several Executed Contracts During Q2 2022 #PBIO @ir_pressurebio
https://www.investorwire.com/newsarticle/?qms...5489287996
https://www.investorwire.com/newsarticle/?qms...5489287996

